Ethical considerations in the restoration of adult screening pathways in the context of COVID-19, developed by the UK National Screening Committee. Category: UncategorisedBy 8 April 2021Leave a commentPost navigationPreviousPrevious post:New JCVI advice on use of the AstraZeneca COVID-19 vaccineNextNext post:Guidance: COVID-19 vaccination: blood clotting information for healthcare professionals
